This year marks 35 years since our institute was founded by the visionary Sir David Weatherall. Join us as we look back on some of our highlights and achievements, ranging from Nobel Prize-winning research to vaccine development 🔬. 🎥 Watch here:

RT @beth_psaila: we are recruiting!! Ads live for 2 research assistants/biobankers and a data coordinator - working on a new @Ludwig_Cancer….

RT @MRC_TIDU: NEW: An international collaboration, initiated by the Jackson Group, has uncovered new information that could help in the dev….

Last month, a team of researchers from @GorielyLab led an interactive educational workshop titled “We Are All Mutants” for two biology classes at @kgvsixthform . Find out more in our latest blog post by @AliMakesHay, @Dale_Maxwell & @ScienceHans -

RT @MRC_MHU: Congratulations to Adam Wilkinson, who has received the 2025 Janet Rowley Award from the @ISEHSociety for his outstanding con….

For International Women's Day tomorrow, we asked some of our women scientists, including @MiraKassouf & @DrSarahGooding, to reflect on why this day is so important. #IWD2025 #InternationalWomensDay . Watch:

RT @oxpolicyengaged: The OPEN Seed Fund is now . open! All the details you need are in the link below but please do also contact the Pol….

RT @rarediseaseday: 💜🌍 Today is Rare Disease Day! 🌍💜. Together, we stand with the 300 million people worldwide living with rare diseases. I….

To conclude our @rarediseaseday series, we spoke with @el_louka26, a clinician scientist researching Paediatric Myelodysplastic Syndromes & Juvenile Myelomonocytic Leukaemia - very rare childhood cancers with no current treatment options available. Watch:

Next in our Rare Disease Day series, we spoke with Yin Dong (@CMS_CDG_Oxford), whose work focuses on Congenital Myasthenia and Congenital Disorders of Glycosylation, which result in muscle weakness and developmental delay. Watch here: @NDCNOxford.

For Rare Disease Day this Friday, we spoke with @DrSarahGooding, a clinician scientist in @Chapman_lab_UK at the MRC WIMM researching multiple myeloma, a currently incurable type of bone marrow cancer that desperately requires friendlier therapies. Watch:

RT @MRC_MHU: NEW preprint from @AbAttacks & colleagues:.

At the MRC WIMM, we foster a strong culture of innovation. We spoke with some of our current and former Group Leaders who have developed their discoveries into commercial ventures to translate their research into clinics and benefit patients:

RT @OxfordMedSci: RESEARCHERS: Join the Oxford Immuno-Oncology Network!. OCION brings together @UniofOxford scientists from different disci….

We've got some great events planned for Green Action Week next week, including a Swap Shop, LEAF Lab Tours and a Charity Bake Sale! 🍃♻️🧁. Find out more:

RT @MRC_TIDU: IMMOX'25 - Genetic Variation & Barrier Immunity, Oxford, UK - March 17th - 19th 2025. EARLY BIRD REGISTRATION still open and….

RT @OxfordMedSci: FUNDING: Medical and Life Sciences Translational Fund (MLSTF) 2025 is accepting applications!. For Oxford researchers to….

NEW: Alison Kay & @AGoriely have been awarded funding for a new public & community engagement project, which will use theatre to explore public perception of a new form of genetic testing. Read more: . This project is also supported by @CPMOxford

RT @OxfordMedSci: TRAINING Data analysis & visualisation in R for biologists. Interactive course aimed at expanding skills to create reprod….

RT @milnetom68: I am two days late with this, but congratulations to Vassi Sharlandjieva for successfully defending her thesis! And a big t….